Image

WB-EMS Effects on Cardiometabolic Risk Factors

WB-EMS Effects on Cardiometabolic Risk Factors

Recruiting
50-70 years
Male
Phase N/A

Powered by AI

Overview

From the age of 50 onwards, there is a disproportionate decline in muscle strength, mass and function, which can be prevented or at least delayed by physical training. Unfortunately, many training programmes are very time-consuming and strenuous and are therefore not carried out consistently. Whole-body electromyostimulation (WB-EMS), a technology in which all major muscle groups are stimulated with an adjusted stimulation level, could be a time-effective and joint-friendly alternative.

However, there are some contraindications to the widespread use of this technology, which are particularly common in middle-aged and elderly people. For example, high blood pressure, which affects more than half of men over the age of 50 in Germany, is considered a contraindication for WB-EMS training. However, this assessment is not very reliable; at least, acute WB-EMS application does not lead to an increase in blood pressure. In addition, there are no study results available for long-term WB-EMS application in people with high blood pressure.

The present study particularly investigate whether and to what extent several weeks of WB-EMS training has an effect on resting blood pressure in people with mild blood pressure. Additionally, the effect of WB-EMS on other cardiometabolic risk factors and physical function will be addressed.

Eligibility

Inclusion Criteria:

  • Grade 1 hypertension: systolic 140 and/or diastolic 90 mmHg
  • overweight or obese (body mass index \> 25 kg/m2)

Exclusion Criteria:

  • blood pressure-lowering pharmacologic therapy.
  • WB-EMS application and regular resistance exercise training
  • Conditions and illnesses that preclude intensive physical exertion
  • Severe cardiac arrhythmia
  • Heart failure
  • acute pulmonary embolism
  • acute myocarditis
  • severe hypertension, e.g. blood pressure \> 200 mmHg systolic and/or \>110 mmHg diastolic
  • Contraindications for bioimpedance analysis (e.g. pacemaker)
  • Contraindications for WB-EMS application (e.g. acute infections/fever, epilepsy)

Study details
    Hypertension
    Metabolic Syndrome
    Hypercholesterolemia
    Hypertriglyceridemia
    Overweight and Obesity

NCT07406191

University of Erlangen-Nürnberg Medical School

14 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.